How many peri colace should i take

In case of overdose, get medical help or contact a Poison Control Center right away. Purpose Stool softener Stimulant laxative. Uses relieves occasional constipation irregularity generally produces bowel movement in 6 to 12 hours. Do not use laxative products for longer than 1 week unless told to do so by a doctor if you are presently taking mineral oil, unless told to do so by a doctor. Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks.

Directions Take only by mouth. The intermittent use of senna should be limited to use under the advice of a qualified health care professional and after safer agents have failed to produce intended results. The safest first-line treatments to use for constipation during pregnancy are those that are not absorbed systemically e. Polyethylene glycol has minimal systemic absorption and is considered an option for chronic constipation during pregnancy. Docusate sodium; senna is generally considered compatible for use in breast-feeding.

Docusate is not systemically absorbed. Senna is not excreted into human milk, but it is a prodrug which is metabolized in vivo to the sennosides. Sennosides are glucosides of rhein, and the sennosides are essentially undetectable in human milk. Rhein appears to be excreted only in minimal amounts. There is a lack of reported adverse events in nursing infants whose mothers ingested sennosides during lactation.

Agents that are non-absorbed or poorly absorbed e. Other agents that may be considered based on lack of systemic effect or lack of reported adverse effects in nursing infants include magnesium hydroxide, polyethylene glycol , and bisacodyl. Nonprescription use of docusate; senna is not recommended in infants. Most nonprescription products may be used in children 2 years and older. While the literature describes off-label use of senna for occasional constipation or for bowel preparation in infants as young as 1 month of age, under a prescriber's advice and observation, commercially available formulations of docusate; senna are not ammenable to use in infants, and some products contain ingredients that may not be safe for neonates.

The OBRA guidelines caution that laxatives may cause flatulence, bloating, and abdominal pain in debilitated or elderly patients. Drugs used to treat constipation, such as laxatives, would counteract the effect of antidiarrheals.

In general, it would be illogical to concurrently administer these drugs at the same time. If an antidiarrheal medication is needed, it would be wise to temporarily discontinue use of agents with laxative effects. Calcium Phosphate, Supersaturated: Moderate Patients should be instructed not to administer additional laxatives or purgative agents during treatment with sodium phosphate monobasic monohydrate; sodium phosphate dibasic anhydrous.

Dichlorphenamide: Moderate Use dichlorphenamide and docusate together with caution. Dichlorphenamide increases potassium excretion and can cause hypokalemia and should be used cautiously with other drugs that may cause hypokalemia including laxatives. Measure potassium concentrations at baseline and periodically during dichlorphenamide treatment. If hypokalemia occurs or persists, consider reducing the dichlorphenamide dose or discontinuing dichlorphenamide therapy.

Loop diuretics: Moderate Loop diuretics may increase the risk of hypokalemia especially in patients receiving prolonged therapy with laxatives.

Mineral Oil: Major The concurrent use of docusate salts with mineral oil to relieve constipation is not recommended because docusate can increase the systemic absorption of mineral oil.

Inflammation of the intestinal mucosa, liver, spleen and lymph nodes may occur due to a foreign body reaction. Mineral oil deposition has been detected at these sites. Sodium Phosphate Monobasic Monohydrate; Sodium Phosphate Dibasic Anhydrous: Moderate Patients should be instructed not to administer additional laxatives or purgative agents during treatment with sodium phosphate monobasic monohydrate; sodium phosphate dibasic anhydrous.

This stimulant laxative-stool softener combination works synergistically to relieve constipation. Get the SingleCare prescription discount card. Dulcolax is an over-the-counter medication that is typically not covered by commercial or Medicare drug insurance plans. Adverse events are rare with Colace. Mild gastrointestinal cramping may occur. Dulcolax at normal doses for short durations of treatment may cause mild gastrointestinal cramping, faintness, nausea, and vomiting.

Dulcolax used long term is likely to cause diarrhea and lead to fluid and electrolyte loss. This can lead to hypokalemia low potassium levels which may be dangerous. Prolonged use can also lead to dependency, and rebound constipation may occur when the medication is stopped.

This list may not include all potential side effects. Please consult your healthcare professional for a complete list. Colace and Dulcolax should be used cautiously in patients on loop diuretics such as furosemide or torsemide.

These diuretics are potassium wasting, and that potassium loss combined with the potential electrolyte imbalance that can result from diarrhea when taking Colace or Dulcolax could lead to hypokalemia.

Colace should not be taken with mineral oil because it can increase systemic absorption of mineral oil. Inflammation of the intestine, liver, spleen, and lymph nodes could occur from mineral oil deposits at these sites leading to a foreign body reaction. Dulcolax is enteric coated and designed to have delayed dissolution. Taking Dulcolax with antacids, H2 blockers, and proton inhibitors may cause the enteric coating to dissolve prematurely leading to stomach irritation or dyspepsia.

Dulcolax should be spaced away from the administration of these drugs by at least one hour. This is not intended to be an all-inclusive list of potential drug interactions. Please consult your pharmacist or healthcare professional for a complete list. You should consult your doctor before using Colace or Dulcolax if you are experiencing nausea, vomiting, or stomach pain.

You should also consult your healthcare provider if you have had a sudden change in bowel movements that have lasted for more than two weeks. When taking Dulcolax, cramping and abdominal discomfort may occur. Do not crush or chew Dulcolax tablets, and do not take Dulcolax within one hour of antacids or milk.

If you have no bowel movement or experience rectal bleeding after taking Dulcolax, stop taking it and call your doctor. Colace is an over-the-counter stool softener used in the prevention and treatment of constipation.

Dulcolax is a stimulant laxative used in the treatment of occasional constipation. Dulcolax is available in enteric-coated 5 mg and 10 mg tablets as well as a 10mg rectal suppository.

While both Colace and Dulcolax are used to treat constipation, they are not the same and do not work in the same way. Colace, a stool softener, helps soften the stool to make it easier to pass. Dulcolax, a stimulant laxative, works by simulating the physical movement of the stool through the digestive tract. Dulcolax produces a bowel movement more quickly than Colace, with the suppository form working within an hour or so of administration.

Colace is typically gentler and causes less discomfort, but may take up to three days to provide relief. Colace has been associated with some cases of fetal malformation, and therefore should only be used when benefits clearly outweigh the risks.

Dulcolax has not shown any undesirable effects and is considered relatively safe for short term use in pregnancy. The risk of dehydration and electrolyte imbalance should be weighed when deciding on constipation treatment in pregnant women, and their healthcare provider should always be consulted.